Single-Cell Factor Localization on Chromatin using Ultra-Low Input Cleavage Under Targets and Release using Nuclease
February 1st, 2022
5.6K views
CUT&RUN and its variants can be used to determine protein occupancy on chromatin. This protocol describes how to determine protein localization on chromatin using single-cell uliCUT&RUN.
Overview
CUT&RUN is a powerful technique for determining protein localization on chromatin, facilitating single-cell analysis in a manual 96-well format. This protocol minimizes input requirements compared to traditional methods like ChIP-seq and can be completed within a day, enabling applications on rare and low-abundance biological samples.
Key Study Components
Research Area
- Chromatin biology
- Single-cell analysis
- Protein localization techniques
Background
- CUT&RUN offers higher signal and lower background compared to conventional methods.
- High dependency on robust antibodies for accurate results.
- Ideal for analyzing precious patient samples and rare cells.
Methods Used
- Manual 96-well format CUT&RUN
- Single-cell sorting using Hoechst 33342 stain
- Proteins extracted and analyzed post-immunoprecipitation
Main Results
- The protocol allows effective protein localization determination in single cells.
- Successful identification of factor localization in low-quality embryonic stem cells.
- Time-efficient procedure compared to existing techniques.
Conclusions
- The study showcases a novel approach to analyzing protein occupancy on chromatin at a single-cell level.
- This technique holds significant promise for future biological research, especially in clinical applications.
Frequently Asked Questions
What is CUT&RUN?
CUT&RUN is a method to determine protein localization on chromatin.
Why is single-cell analysis important?
It allows for the study of rare cell types and individual cellular responses.
What are the main advantages of this protocol?
It requires lower cell input and shorter processing time than traditional methods.
What is the main limitation of CUT&RUN?
It depends on the quality and specificity of the antibodies used.
How quickly can results be obtained?
The protocol can be completed in a single day.
Can this method be applied to clinical samples?
Yes, it is particularly beneficial for precious patient samples.
What types of proteins can be studied using this protocol?
Any protein of interest, provided the appropriate antibodies are available.
Executive Industry Relevance
Single-cell uliCUT&RUN enables precise mapping of chromatin-bound factors in ultra-low input samples, addressing a critical bottleneck in early discovery and target validation. This approach supports predictive confidence in regulatory element identification and facilitates mechanistic de-risking for rare or precious biological samples, including those from patient-derived material. Its rapid, scalable workflow positions it as a strategic asset for portfolio triage and translational research continuity.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables high-resolution mapping of protein-DNA interactions at the single-cell level for functional target validation.
- Supports mechanistic de-risking by clarifying factor localization in rare or heterogeneous cell populations.
- Facilitates predictive confidence in regulatory element assignment and pathway interrogation.
Screening & Assay Development
- Prepares validated chromatin profiles for downstream screening of transcription factors and chromatin modifiers.
- Delivers quantitative, reproducible readouts suitable for assay standardization and platform scalability.
- Enables reliable evaluation of antibody specificity and sample quality prior to large-scale screening.
Translational & Preclinical Research
- Aligns chromatin factor localization with disease-relevant biomarkers in rare or patient-derived samples.
- Maintains continuity from discovery through preclinical validation by supporting low-input and single-cell workflows.
- Reduces biological risk in translational studies by enabling robust, quantitative chromatin profiling.
Pipeline & Workflow Integration
uliCUT&RUN integrates into the discovery-to-preclinical continuum by enabling hypothesis-driven chromatin mapping from early discovery through lead identification and translational research.
- Discovery Biology: Supports hypothesis testing and pathway clarification by mapping protein-DNA interactions in single cells.
- Screening: Provides quantitative, reproducible chromatin occupancy data for assay readiness and compound evaluation.
- Analytics: Generates high-resolution, antibody-specific enrichment profiles for comparative analysis across conditions.
- Translational Research: Facilitates biomarker alignment and risk-adjusted advancement in rare or precious samples.
- Enterprise Reuse: Offers a scalable, reusable platform for chromatin profiling across diverse biological systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Delivers rapid, standardized, and reproducible workflows for low-input and single-cell samples.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling robust data from limited material.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of discovery and translational programs.
Implementation Considerations
- Requires expertise in single-cell handling, chromatin biology, and antibody validation.
- Demands access to 96-well magnetic racks, multichannel pipettes, and fragment analysis instrumentation.
- Necessitates rigorous antibody specificity testing and cross-team standardization for reproducibility.
- Adaptable to various cell types but dependent on sample quality and antibody performance.
- Limited by antibody robustness and potential for over-digestion if temperature control is not maintained.
Biopharma FAQs
Why does null hypothesis testing matter for single-cell factor localization?
Null hypothesis testing in uliCUT&RUN ensures that observed chromatin binding patterns are statistically significant and not due to background or non-specific antibody interactions. This is critical for confidently validating regulatory targets in discovery-stage research. Reliable statistical thresholds support robust target nomination and portfolio triage.
How does independent variable isolation fit the uliCUT&RUN workflow?
Isolating variables such as antibody specificity and cell quality in uliCUT&RUN allows teams to attribute chromatin binding events directly to the factor of interest. This isolation is essential for mechanistic de-risking and for establishing causality in early discovery pipelines.
What do quantitative dependent variable measurements enable in single-cell uliCUT&RUN?
Quantitative measurements of DNA fragment enrichment at specific loci enable precise comparison of protein occupancy across single cells and conditions. This supports reproducible assay development and informs downstream screening and translational research decisions.
Why are replication requirements important for cross-functional collaboration in chromatin profiling?
Replication in uliCUT&RUN ensures that chromatin binding profiles are consistent and reproducible across experiments and teams. This reliability is vital for cross-functional collaboration, enabling data integration and confidence in advancing targets through the pipeline.
What statistical analysis capabilities are required before implementing single-cell uliCUT&RUN?
Robust statistical analysis is needed to distinguish true factor enrichment from background and to validate antibody specificity. Teams must implement fragment size distribution analysis, enrichment heat maps, and appropriate controls to ensure data quality before broader deployment.
Chapters in this video
0:04
Introduction
1:17
Pre-Blocking of Samples to Prevent Early Digestion by MNase
1:46
Addition of Primary Antibody
3:09
Addition of pA-MNase or pA/G-MNase
4:04
Directed DNA Digestion
5:04
Sample Fractionation and DNA Extraction
7:09
Results: Protein Localization on Chromatin Using Single Cell uliCUT&RUN
8:54
Conclusion
